Show simple item record

Constitutive activation of pp125fak in newly isolated human breast cancer cell lines

dc.contributor.authorIgnatoski, Kathleen M. Woodsen_US
dc.contributor.authorEthier, Stephen P.en_US
dc.date.accessioned2006-09-11T14:26:11Z
dc.date.available2006-09-11T14:26:11Z
dc.date.issued1999-03en_US
dc.identifier.citationIgnatoski, Kathleen M. Woods; Ethier, Stephen P.; (1999). "Constitutive activation of pp125fak in newly isolated human breast cancer cell lines." Breast Cancer Research and Treatment 54(2): 173-182. <http://hdl.handle.net/2027.42/44204>en_US
dc.identifier.issn1573-7217en_US
dc.identifier.issn0167-6806en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/44204
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=10424408&dopt=citationen_US
dc.description.abstractOur laboratory has developed twelve human breast cancer cell lines from primary and metastatic sites. In this report we demonstrate that eight of eight breast cancer cell lines examined exhibit constitutively tyrosine phosphorylated and enzymatically active endogenous pp125fak when grown in monolayer. The activation status of pp125fak in breast cancer cells in monolayer is significantly elevated over that exhibited by normal mammary epithelial cells cultured under the same conditions. Constitutive activation of pp125fak is the only characteristic so far studied that all of these breast cancer cell lines have in common. In contrast to HBC cells, tyrosine phosphorylation of pp125fak in HME cells was low or absent in monolayer culture but was induced to high levels by culturing the cells in Matrigel. Thus tyrosine phosphorylation and activation of pp125fak is a regulated process in normal mammary epithelial cells, but is constitutive in breast cancer cells. Finally, analysis of the ability of normal human mammary epithelial cells and breast cancer cell lines to grow under anchorage‐independent conditions indicated that normal human mammary epithelial cells rapidly and uniformly lost viability when not substrate‐attached, whereas all of the breast cancer cell lines survived for a 3‐week culture period. Furthermore, a subset of the breast cancer cell lines grew to form large colonies under anchorage‐independent conditions. Interestingly, pp125fak activation decreased dramatically in HBC cells cultured for two weeks in suspension, suggesting that activation of this kinase is not necessary for long‐term growth under anchorage‐independent conditions. These results suggest that constitutive activation of pp125fak results in preferential survival of human breast cancer cells under anchorage‐independent conditions but that activation of pp125fak is not the sole mediator of anchorage‐independent colony formation.en_US
dc.format.extent166860 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherKluwer Academic Publishers; Springer Science+Business Mediaen_US
dc.subject.otherMedicine & Public Healthen_US
dc.subject.otherOncologyen_US
dc.subject.otherPp125fak Activationen_US
dc.subject.otherAnchorage Independent Growthen_US
dc.subject.otherFocal Adhesion Kinaseen_US
dc.subject.otherBreast Cancer Cell Linesen_US
dc.subject.otherExtracellular Matrixen_US
dc.titleConstitutive activation of pp125fak in newly isolated human breast cancer cell linesen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelOncology and Hematologyen_US
dc.subject.hlbsecondlevelPublic Healthen_US
dc.subject.hlbsecondlevelObstetrics and Gynecologyen_US
dc.subject.hlbsecondlevelOtolaryngologyen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbsecondlevelOphthalmologyen_US
dc.subject.hlbsecondlevelNeurosciencesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Radiation Oncology, Division of Radiation and Cancer Biology, University of Michigan Medical School, Ann Arbor, MI, USAen_US
dc.contributor.affiliationumDepartment of Radiation Oncology, Division of Radiation and Cancer Biology, University of Michigan Medical School, Ann Arbor, MI, USAen_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.identifier.pmid10424408en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/44204/1/10549_2004_Article_200693.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1023/A:1006135331912en_US
dc.identifier.sourceBreast Cancer Research and Treatmenten_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.